DK30886D0 - Peptidderivater - Google Patents

Peptidderivater

Info

Publication number
DK30886D0
DK30886D0 DK30886A DK30886A DK30886D0 DK 30886 D0 DK30886 D0 DK 30886D0 DK 30886 A DK30886 A DK 30886A DK 30886 A DK30886 A DK 30886A DK 30886 D0 DK30886 D0 DK 30886D0
Authority
DK
Denmark
Prior art keywords
peptide derivatives
peptide
derivatives
Prior art date
Application number
DK30886A
Other languages
English (en)
Other versions
DK30886A (da
DK172736B1 (da
Inventor
Scott Haven Bergeson
Philis Duke Edwards
John Anthony Schwartz
Andrew Shaw
Mark Morris Stein
Diane Amy Trainor
Richard Alan Wildonger
Donald John Wolanin
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858501523A external-priority patent/GB8501523D0/en
Priority claimed from GB858501524A external-priority patent/GB8501524D0/en
Priority claimed from GB858501522A external-priority patent/GB8501522D0/en
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of DK30886D0 publication Critical patent/DK30886D0/da
Publication of DK30886A publication Critical patent/DK30886A/da
Application granted granted Critical
Publication of DK172736B1 publication Critical patent/DK172736B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/01—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms
    • C07C205/02—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/43—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198600308A 1985-01-22 1986-01-21 3,N-disubstituerede prolinamidderivater, fremgangsmåde og mellemprodukter til fremstilling heraf samt farmaceutiske midler DK172736B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB858501523A GB8501523D0 (en) 1985-01-22 1985-01-22 Tripeptide derivatives
GB858501524A GB8501524D0 (en) 1985-01-22 1985-01-22 Tetrapeptide derivatives
GB8501524 1985-01-22
GB8501522 1985-01-22
GB858501522A GB8501522D0 (en) 1985-01-22 1985-01-22 Dipeptide derivatives
GB8501523 1985-01-22

Publications (3)

Publication Number Publication Date
DK30886D0 true DK30886D0 (da) 1986-01-21
DK30886A DK30886A (da) 1986-07-23
DK172736B1 DK172736B1 (da) 1999-06-21

Family

ID=27262565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198600308A DK172736B1 (da) 1985-01-22 1986-01-21 3,N-disubstituerede prolinamidderivater, fremgangsmåde og mellemprodukter til fremstilling heraf samt farmaceutiske midler

Country Status (25)

Country Link
US (2) US4910190A (da)
EP (1) EP0189305B1 (da)
JP (2) JPH0759591B2 (da)
KR (1) KR910002689B1 (da)
CN (1) CN1027640C (da)
AU (1) AU594658B2 (da)
CA (1) CA1341023C (da)
CZ (1) CZ278063B6 (da)
DE (1) DE3686172T2 (da)
DK (1) DK172736B1 (da)
ES (3) ES8706169A1 (da)
FI (1) FI84171C (da)
GB (1) GB8600263D0 (da)
GR (1) GR860169B (da)
HK (1) HK18097A (da)
HU (1) HU206370B (da)
IE (1) IE58957B1 (da)
IL (1) IL77680A (da)
NO (1) NO169493C (da)
PH (1) PH26575A (da)
PL (1) PL150268B1 (da)
PT (1) PT81887B (da)
SK (1) SK278095B6 (da)
UA (1) UA39093C2 (da)
ZW (1) ZW1486A1 (da)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
EP0204571B1 (en) * 1985-06-07 1992-01-22 Ici Americas Inc. Selected difluoro derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
US5182263A (en) * 1988-04-25 1993-01-26 Hoffmann-La Roche Inc. Analogs of tyrosine sulfate or tyrosine phosphate containing peptides
US5296608A (en) * 1988-04-25 1994-03-22 Hoffman-La Roche Inc. Intermediates for analogs of tyrosine sulfate or tyrosine phosphate containing peptides
IL90872A0 (en) * 1988-07-08 1990-02-09 Smithkline Beckman Corp Retroviral protease binding peptides
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
GB8910550D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted amides
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
EP0458536B1 (en) * 1990-05-24 1998-03-18 Zeneca Limited Therapeutic agent for treatment and prevention of adult respiratory distress syndrome
IE911698A1 (en) * 1990-05-24 1991-12-04 Ici Plc Therapeutic compound
GB9014132D0 (en) * 1990-06-25 1990-08-15 Ici Plc Agent for therapy
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
US5521179A (en) * 1991-04-18 1996-05-28 Zeneca Limited Heterocyclic amides
GB9207145D0 (en) * 1991-04-18 1992-05-13 Ici Plc Heterocyclic amides
US5340801A (en) * 1991-05-08 1994-08-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cholecystokinin and gastrin antagonistic properties
ATE181925T1 (de) * 1991-05-23 1999-07-15 Merrell Pharma Inc Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau
GB9113164D0 (en) * 1991-06-18 1991-08-07 Ici Plc Pharmaceutical agent
AU2390892A (en) * 1991-08-08 1993-03-02 Yamanouchi Pharmaceutical Co., Ltd. Urea derivative
GB9216272D0 (en) * 1991-08-15 1992-09-09 Ici Plc Substituted heterocycles
AU658426B2 (en) * 1991-08-15 1995-04-13 Zeneca Limited Substituted heterocycles
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5486529A (en) * 1992-04-16 1996-01-23 Zeneca Limited Certain pyridyl ketones for treating diseases involving leukocyte elastase
JPH07505877A (ja) * 1992-04-16 1995-06-29 ゼネカ・リミテッド α−アミノボロン酸ペプチド及びエラスターゼ阻害剤としてのそれらの使用
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9214053D0 (en) * 1992-07-02 1992-08-12 Ici Plc Heterocyclic amides
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
FR2719589B1 (fr) * 1994-05-05 1996-06-14 Adir Nouveaux peptides dérivés de trifluorométhylcétones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6693072B2 (en) * 1994-06-02 2004-02-17 Aventis Pharmaceuticals Inc. Elastase inhibitors
HU221197B1 (en) * 1994-06-02 2002-08-28 Aventis Pharma Inc Elastase inhibitor tripeptides and pharmaceutical compositions comprising thereof
DK0763055T3 (da) * 1994-06-02 2000-05-08 Merrell Pharma Inc Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf
ES2161293T3 (es) * 1994-06-02 2001-12-01 Merrell Pharma Inc Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
GB9502152D0 (en) * 1995-02-03 1995-03-29 Zeneca Ltd Proline derivatives
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6939855B2 (en) * 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US6362341B1 (en) 1997-07-31 2002-03-26 Athena Neurosciences, Inc. Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
US6423688B1 (en) 1997-07-31 2002-07-23 Athena Neurosciences, Inc. Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US6559127B1 (en) 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6583139B1 (en) * 1997-07-31 2003-06-24 Eugene D. Thorsett Compounds which inhibit leukocyte adhesion mediated by VLA-4
US7030114B1 (en) 1997-07-31 2006-04-18 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6492421B1 (en) 1997-07-31 2002-12-10 Athena Neurosciences, Inc. Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US6682554B2 (en) * 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
JP2000256396A (ja) 1999-03-03 2000-09-19 Dainippon Pharmaceut Co Ltd 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤
GB9928882D0 (en) * 1999-12-08 2000-02-02 Zeneca Ltd Assay method
US6403612B2 (en) * 2000-01-31 2002-06-11 Merck & Co., Inc. Thrombin receptor antagonists
US20040006093A1 (en) * 2000-10-17 2004-01-08 Thorsett Eugene D. Compounds which inhibit leukocyte adhesion mediated by VLA-4
WO2003064605A2 (en) 2002-01-28 2003-08-07 Ambion, Inc. Crude biological derivatives competent for nucleic acid detection
KR20040081182A (ko) * 2002-02-05 2004-09-20 다이닛본 세이야꾸 가부시끼가이샤 엘라스타제-저해 활성을 가진 이종고리 화합물 및 그 중간체
US7964350B1 (en) 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
WO2010071833A1 (en) 2008-12-19 2010-06-24 Life Technologies Corporation Proteinase k inhibitors, methods and compositions therefor
WO2017127306A1 (en) 2016-01-18 2017-07-27 Arisan Therapeutics Adamatane derivatives for the treatment of filovirus infection
US10710957B2 (en) 2017-01-09 2020-07-14 University Of Central Florida Research Foundation, Inc. Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
WO2019018185A1 (en) 2017-07-15 2019-01-24 Arisan Therapeutics Inc. ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB195212A (en) * 1922-01-30 1923-03-29 Edward Crawshaw Improvements in expansion joints between steam boilers and their settings or flue walls
US4277395A (en) * 1980-06-16 1981-07-07 Richardson-Merrell Inc. Novel enzyme inhibitors
EP0124317B1 (en) * 1983-04-27 1990-04-11 Ici Americas Inc. Proline derivatives
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
CH672792A5 (da) * 1985-02-19 1989-12-29 Sandoz Ag
EP0204571B1 (en) * 1985-06-07 1992-01-22 Ici Americas Inc. Selected difluoro derivatives
GB8711748D0 (en) * 1986-06-05 1987-06-24 Ici America Inc Difluoro keto compounds

Also Published As

Publication number Publication date
JPH05246984A (ja) 1993-09-24
CS39586A3 (en) 1992-01-15
DE3686172T2 (de) 1993-01-14
ES557048A0 (es) 1987-08-01
JPH0759591B2 (ja) 1995-06-28
FI84171B (fi) 1991-07-15
FI860281A0 (fi) 1986-01-21
EP0189305A2 (en) 1986-07-30
HU206370B (en) 1992-10-28
FI860281A7 (fi) 1986-07-23
ES551113A0 (es) 1987-05-16
PT81887A (en) 1986-02-01
SK278095B6 (en) 1995-12-06
DK30886A (da) 1986-07-23
ES557363A0 (es) 1988-07-01
EP0189305B1 (en) 1992-07-29
JPS61218518A (ja) 1986-09-29
IE58957B1 (en) 1993-12-01
IL77680A (en) 1990-12-23
CZ278063B6 (en) 1993-08-11
IE860180L (en) 1986-07-22
HUT39464A (en) 1986-09-29
US4910190A (en) 1990-03-20
NO860190L (no) 1986-07-23
AU594658B2 (en) 1990-03-15
ZW1486A1 (en) 1987-09-30
GR860169B (en) 1986-05-15
PL150268B1 (en) 1990-05-31
ES8802526A1 (es) 1988-07-01
UA39093C2 (uk) 2001-06-15
CN86101066A (zh) 1986-11-05
KR860005835A (ko) 1986-08-13
DE3686172D1 (de) 1992-09-03
ES8707551A1 (es) 1987-08-01
JPH0680039B2 (ja) 1994-10-12
GB8600263D0 (en) 1986-02-12
CN1027640C (zh) 1995-02-15
PL257573A1 (en) 1987-03-23
PT81887B (pt) 1988-05-27
PH26575A (en) 1992-08-19
HK18097A (en) 1997-02-13
ES8706169A1 (es) 1987-05-16
CA1341023C (en) 2000-06-13
NO169493C (no) 1992-07-01
DK172736B1 (da) 1999-06-21
NO169493B (no) 1992-03-23
EP0189305A3 (en) 1988-10-05
FI84171C (fi) 1991-10-25
KR910002689B1 (ko) 1991-05-03
AU5262386A (en) 1986-07-31
US5726158A (en) 1998-03-10

Similar Documents

Publication Publication Date Title
KR860005835A (ko) 펩티드유도체
DK133686D0 (da) Dipeptidderivater
FI874495A7 (fi) Peptidijohdannaisia
DK22588A (da) Peptidderivater
FI862434A7 (fi) Foerfarande foer framstaellning av difluor-ketonpeptidderivat.
DE3685167D1 (de) Calcitoningen-verwandte peptidderivate.
DK600586A (da) Protein
DK133786D0 (da) Praeparater
BR8606663A (pt) Derivados de triazolil-quinolina
DK109186A (da) Dihydropyridazinonderivater
DK414586A (da) Peptidforbindelser
DK24986D0 (da) Praeparater
DK419486D0 (da) Proteinekspression
DK491786D0 (da) Dichloranilinderivater
DK4390D0 (da) Peptidderivater
DK556386A (da) Quinilinderivater
DK303886A (da) Secocanthinderivater
DE3662889D1 (de) Tetrahydrofurancarboxylic-acid derivatives
KR880700821A (ko) 데--데옥시테이코플라닌 유도체
DK679488A (da) Peptidderivater
DK466086D0 (da) Exogent syrnede antacidiumpraeparater
DK109086D0 (da) 2-aminopyrimidinonderivater
DE3662890D1 (de) Furobenzisoxazole derivatives
ATE78829T1 (de) Peptid-derivate.
DK395685D0 (da) Peptider

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK